In demyelinating diseases such as multiple sclerosis (MS), the myelin sheaths are damaged, leading to impaired neural function. OPCs play a crucial role in the repair process by differentiating into oligodendrocytes to remyelinate the affected axons. However, in chronic cases of MS, the regenerative capacity of OPCs may be insufficient, leading to persistent demyelination and neurological deficits.
